{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T18:26:58Z","timestamp":1771612018645,"version":"3.50.1"},"reference-count":43,"publisher":"Impact Journals, LLC","issue":"52","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,12,27]]},"DOI":"10.18632\/oncotarget.13413","type":"journal-article","created":{"date-parts":[[2016,11,17]],"date-time":"2016-11-17T01:12:28Z","timestamp":1479345148000},"page":"86374-86387","source":"Crossref","is-referenced-by-count":34,"title":["Re-purposing of curcumin as an anti-metastatic agent for the treatment of epithelial ovarian cancer: <i>in vitro<\/i> model using cancer stem cell enriched ovarian cancer spheroids"],"prefix":"10.18632","volume":"7","author":[{"given":"Misi","family":"He","sequence":"first","affiliation":[{"name":"Cardiff China Medical Research Collaborative, School of Medicine, Cardiff University, Cardiff CF14 4XN, UK"},{"name":"Department of Gynaecologic Oncology, Chongqing Cancer Institute, Chongqing, 400030, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Gynaecologic Oncology, Chongqing Cancer Institute, Chongqing, 400030, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongling","family":"Zou","sequence":"additional","affiliation":[{"name":"Department of Gynaecologic Oncology, Chongqing Cancer Institute, Chongqing, 400030, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic surgery, Chongqing Hospital of Traditional Chinese Medicine, Chongqing, 400021, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Lopes-Bastos","sequence":"additional","affiliation":[{"name":"Cardiff China Medical Research Collaborative, School of Medicine, Cardiff University, Cardiff CF14 4XN, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen G","family":"Jiang","sequence":"additional","affiliation":[{"name":"Cardiff China Medical Research Collaborative, School of Medicine, Cardiff University, Cardiff CF14 4XN, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Chester","sequence":"additional","affiliation":[{"name":"Institute of Cancer and Genetics, School of Medicine, Cardiff University, Cardiff, Cardiff CF14 4XN, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Gynaecologic Oncology, Chongqing Cancer Institute, Chongqing, 400030, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Cai","sequence":"additional","affiliation":[{"name":"Cardiff China Medical Research Collaborative, School of Medicine, Cardiff University, Cardiff CF14 4XN, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2016,11,16]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","article-title":"Cancer statistics, 2013","volume":"63","author":"Jemal","year":"2013","journal-title":"CA Cancer J Clin"},{"key":"2","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0140-6736(10)62231-3","article-title":"Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data","volume":"377","author":"Marrett","year":"2011","journal-title":"Lancet (London, England)"},{"key":"3","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/S1470-2045(11)70123-1","article-title":"Evolution of platinum resistance in high-grade serous ovarian cancer","volume":"12","author":"Brenton","year":"2011","journal-title":"Lancet Oncol"},{"key":"4","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/nm1469","article-title":"Tumor metastasis: mechanistic insights and clinical challenges","volume":"12","author":"Steeg","year":"2006","journal-title":"Nat Med"},{"key":"5","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.2353\/ajpath.2010.100105","article-title":"Ovarian cancer development and metastasis","volume":"177","author":"Lengyel","year":"2010","journal-title":"Am J Pathol"},{"key":"6","doi-asserted-by":"crossref","first-page":"e84941","DOI":"10.1371\/journal.pone.0084941","article-title":"Ovarian cancer spheroid cells with stem cell-like properties contribute to tumor generation, metastasis and chemotherapy resistance through hypoxia-resistant metabolism","volume":"9","author":"Odunsi","year":"2014","journal-title":"PLoS ONE"},{"key":"7","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1002\/ijc.24188","article-title":"Compact spheroid formation by ovarian cancer cells is associated with contractile behavior and an invasive phenotype","volume":"124","author":"Brown","year":"2009","journal-title":"Int J Cancer"},{"key":"8","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12943-015-0417-y","article-title":"A critical role of Oct4A in mediating metastasis and disease-free survival in a mouse model of ovarian cancer","volume":"14","author":"Ahmed","year":"2015","journal-title":"Mol Cancer"},{"key":"9","first-page":"185","article-title":"Curcumin differs from tetrahydrocurcumin for molecular targets, signaling pathways and cellular responses","volume":"20","author":"Prasad","year":"2015","journal-title":"Molecules (Basel, Switzerland)"},{"key":"10","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.3892\/or.2015.4413","article-title":"Curcumin induces autophagy, inhibits proliferation and invasion by downregulating AKT\/mTOR signaling pathway in human melanoma cells","volume":"35","author":"Song","year":"2016","journal-title":"Oncol Rep"},{"key":"11","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3892\/or.2014.3206","article-title":"Curcumin suppresses cell proliferation through inhibition of the Wnt\/beta-catenin signaling pathway in medulloblastoma","volume":"32","author":"Tang","year":"2014","journal-title":"Oncol Rep"},{"key":"12","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.cbi.2009.06.012","article-title":"Potent growth suppressive activity of curcumin in human breast cancer cells: Modulation of Wnt\/beta-catenin signaling","volume":"181","author":"Ralhan","year":"2009","journal-title":"Chem Biol Interact"},{"key":"13","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/s10059-013-0038-5","article-title":"Curcumin induces apoptosis in human colorectal carcinoma (HCT-15) cells by regulating expression of Prp4 and p53","volume":"35","author":"Lee","year":"2013","journal-title":"Mol Cell"},{"key":"14","doi-asserted-by":"crossref","first-page":"6704","DOI":"10.1158\/0008-5472.CAN-09-1298","article-title":"Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells","volume":"69","author":"Sarkar","year":"2009","journal-title":"Cancer Res"},{"key":"15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/mc.20571","article-title":"Curcumin-induced apoptosis in ovarian carcinoma cells is p53-independent and involves p38 mitogen-activated protein kinase activation and downregulation of Bcl-2 and survivin expression and Akt signaling","volume":"49","author":"Hoskin","year":"2010","journal-title":"Mol Carcinog"},{"key":"16","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2741\/s272","article-title":"Curcumin: the multi-targeted therapy for cancer regression","volume":"4","author":"Sa","year":"2012","journal-title":"Front Biosci (Scholar edition)"},{"key":"17","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.intimp.2011.12.009","article-title":"Inhibition of the NF-kappaB signaling pathway by the curcumin analog, 3,5-Bis(2-pyridinylmethylidene)-4-piperidone (EF31): anti-inflammatory and anti-cancer properties","volume":"12","author":"Pace","year":"2012","journal-title":"Int Immunopharmacol"},{"key":"18","first-page":"3185","article-title":"Curcumin inhibits proliferation of colorectal carcinoma by modulating Akt\/mTOR signaling","volume":"29","author":"Evers","year":"2009","journal-title":"Anticancer Res"},{"key":"19","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s13346-012-0079-x","article-title":"Novel strategies targeting cancer stem cells through phytochemicals and their analogs","volume":"3","author":"Sarkar","year":"2013","journal-title":"Drug Deliv Transl Res"},{"key":"20","doi-asserted-by":"crossref","first-page":"8414","DOI":"10.1038\/sj.onc.1205947","article-title":"Beta-catenin-mediated transactivation and cell-cell adhesion pathways are important in curcumin (diferuylmethane)-induced growth arrest and apoptosis in colon cancer cells","volume":"21","author":"Narayan","year":"2002","journal-title":"Oncogene"},{"key":"21","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/mc.20604","article-title":"Curcumin inhibits the Sonic Hedgehog signaling pathway and triggers apoptosis in medulloblastoma cells","volume":"49","author":"Aboussekhra","year":"2010","journal-title":"Mol Carcinog"},{"key":"22","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1002\/cncr.21904","article-title":"Notch-1 down-regulation by curcumin is associated with the inhibition of cell growth and the induction of apoptosis in pancreatic cancer cells","volume":"106","author":"Sarkar","year":"2006","journal-title":"Cancer"},{"key":"23","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1208\/s12248-012-9432-8","article-title":"Therapeutic roles of curcumin: lessons learned from clinical trials","volume":"15","author":"Aggarwal","year":"2013","journal-title":"AAPS J"},{"key":"24","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.stem.2011.04.007","article-title":"Eyes wide open: a critical review of sphere-formation as an assay for stem cells","volume":"8","author":"Doetsch","year":"2011","journal-title":"Cell Stem Cell"},{"key":"25","doi-asserted-by":"crossref","first-page":"e0117776","DOI":"10.1371\/journal.pone.0117776","article-title":"Characterization and propagation of tumor initiating cells derived from colorectal liver metastases: trials, tribulations and a cautionary note","volume":"10","author":"Brown","year":"2015","journal-title":"PloS ONE"},{"key":"26","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/cpr.12038","article-title":"Enrichment of ovarian cancer stem-like cells is associated with epithelial to mesenchymal transition through an miRNA-activated AKT pathway","volume":"46","author":"Lai","year":"2013","journal-title":"Cell Prolif"},{"key":"27","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1038\/onc.2014.178","article-title":"beta-Catenin-regulated ALDH1A1 is a target in ovarian cancer spheroids","volume":"34","author":"Matei","year":"2015","journal-title":"Oncogene"},{"key":"28","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1365-2184.2009.00604.x","article-title":"In vitro three-dimensional modelling of human ovarian surface epithelial cells","volume":"42","author":"Dafou","year":"2009","journal-title":"Cell Prolif"},{"key":"29","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/aps.2013.27","article-title":"Understanding and targeting cancer stem cells: therapeutic implications and challenges","volume":"34","author":"Chen","year":"2013","journal-title":"Acta Pharmacol Sin"},{"key":"30","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrc3432","article-title":"Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research","volume":"13","author":"Kaye","year":"2013","journal-title":"Nat Rev"},{"key":"31","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nrc1611","article-title":"Ovarian cancer metastasis: integrating insights from disparate model organisms","volume":"5","author":"Montell","year":"2005","journal-title":"Nat Rev"},{"key":"32","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ygyno.2013.03.026","article-title":"An international assessment of ovarian cancer incidence and mortality","volume":"130","author":"Goff","year":"2013","journal-title":"Gynecol Oncol"},{"key":"33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neo.2014.12.004","article-title":"Spherical cancer models in tumor biology","volume":"17","author":"Dangles-Marie","year":"2015","journal-title":"Neoplasia"},{"key":"34","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1177\/1758834014544121","article-title":"Treatment options in recurrent ovarian cancer: latest evidence and clinical potential","volume":"6","author":"Ledermann","year":"2014","journal-title":"Ther Adv Med Oncol"},{"key":"35","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nrc3144","article-title":"Rethinking ovarian cancer: recommendations for improving outcomes","volume":"11","author":"Gabra","year":"2011","journal-title":"Nat Rev"},{"key":"36","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1158\/1078-0432.CCR-12-2243","article-title":"New strategies in the treatment of ovarian cancer: current clinical perspectives and future potential","volume":"19","author":"Kaye","year":"2013","journal-title":"Clin Cancer Res"},{"key":"37","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/biof.1065","article-title":"Molecular mechanisms of curcumin action: signal transduction","volume":"39","author":"Lee","year":"2013","journal-title":"Biofactors"},{"key":"38","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1757-2215-3-11","article-title":"Curcumin induces chemo\/radio-sensitization in ovarian cancer cells and curcumin nanoparticles inhibit ovarian cancer cell growth","volume":"3","author":"Chauhan","year":"2010","journal-title":"J Ovarian Res"},{"key":"39","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.bbrc.2015.09.175","article-title":"Curcumin inhibits development and cell adhesion in Dictyostelium discoideum: Implications for YakA signaling and GST enzyme function","volume":"467","author":"Walters","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"40","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1590\/S1807-59322010000400012","article-title":"Association between decreases in type V collagen and apoptosis in mouse lung chemical carcinogenesis: a preliminary model to study cancer cell behavior","volume":"65","author":"Capelozzi","year":"2010","journal-title":"Clinics (Sao Paulo)"},{"key":"41","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1007\/s00018-008-7452-4","article-title":"Curcumin: from ancient medicine to current clinical trials","volume":"65","author":"Torti","year":"2008","journal-title":"Cell Mol Life Sci"},{"key":"42","doi-asserted-by":"crossref","unstructured":"Tsai, Liu, Chen, Chou, Cheng, Hwang, Chong. Curcumin Inhibits Non-Small Cell Lung Cancer Cells Metastasis through the Adiponectin\/NF-kappab\/MMPs Signaling Pathway. PLoS ONE. 2015; 10:e0144462.","DOI":"10.1371\/journal.pone.0144462"},{"key":"43","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1177\/1087057114521867","article-title":"A New Bliss Independence Model to Analyze Drug Combination Data","volume":"19","author":"Yang","year":"2014","journal-title":"J Biomol Screen"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.13413","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T16:37:21Z","timestamp":1594831041000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.13413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,16]]},"references-count":43,"journal-issue":{"issue":"52","published-print":{"date-parts":[[2016,12,27]]}},"alternative-id":["13413","27863439"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.13413","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,16]]}}}